Georgia, which has the highest rate of new HIV infections, is moving to expand access to PrEP and PEP through local pharmacies — a step supporters say could reduce disparities and prevent new cases.

PrEP has been available for more than a decade, but billing mistakes, lack of awareness, and lingering stigma keep many people from getting the lifesaving HIV prevention medication.

Preventive health services, such as cancer screenings, statins, hepatitis testing and PrEP for HIV, are at risk. Here’s how to save them.

The long-anticipated approval of lenacapavir as a once every six-month injectable option for PrEP is a welcome development in the fight to end HIV as an epidemic. It is also a testament to the value…

This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that lenacapavir launches at the exact time that millions of Americans lose insur...

“The political whiplash is frustrating, but the generational fear is worse,” writes Sean Leviashvili. “Still, I know where I come from. I come from a community of fighters.”

Late Sunday night the House Energy & Commerce (E&C) Committee released the text of their reconciliation bill. It shows that the House majority intends to carry out the largest cut to Medicaid ever by…

The Trump Administration’s plan to hollow out funding streams could decimate agencies in poor, conservative states that rely primarily on federal dollars.

Experts weigh in on the SCOTUS case that could decide access to cost-free preventive care, like cancer screenings and PrEP to prevent HIV.

Confusion about the purpose of the Ryan White HIV/AIDS Program from political appointees unfamiliar with public health programs could be a reason the Trump administration is considering proposals to c...

The move comes after a series of cuts to prevention and treatment efforts worldwide. Some functions might be moved to another agency, officials said.

The sudden halt of USAID funding has forced AVAC and partners to suspend essential programs that accelerate HIV prevention research, most notably the CASPR project. AVAC and our African civil society ...

The settlement in U.S. v. Gilead could disturb the model of public-private partnership that sustains many of the United States’ most important medical breakthroughs.

The rapid dismantling of US democratic norms over the past 3 weeks – including fundamental government protections and structures – threatens the nation’s democracy, diversity, society, and economy.

PrEP4All and AVAC ask HIV funders to adapt to urgent threats.

Sign in to Bloomberg Law for access to our comprehensive legal research software.

PrEP advocates say that the threat of funding cuts and policy changes by the incoming power players could jeopardize PrEP access and the push toward ending the HIV epidemic.

Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the end of January.